| Makale Türü |
|
||
| Dergi Adı | ACS Omega (Q2) | ||
| Dergi ISSN | 2470-1343 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 06-2025 |
| Cilt / Sayı / Sayfa | 10 / 23 / 25027–25038 | DOI | 10.1021/acsomega.5c02662 |
| Makale Linki | https://doi.org/10.1021/acsomega.5c02662 | ||
| Özet |
| Diabetes is one of the most important chronic and metabolic health problems seen as an epidemic of the 21st century. The incidence of diabetes is gradually increasing, and different methods are used to treat it. Apitherapy products such as honey, propolis, royal jelly, and bee venom can be used as an alternative to treat diabetes and reduce symptoms. One of these apitherapy products is Apilarnil, which has not yet become popular. The hypolipidemic, hepatoprotective, androgenic, anabolic, and immune system enhancing properties of Apilarnil indicate that it may be effective in the treatment of type 2 diabetes or in reducing the symptoms. The study aimed to determine the therapeutic effect of Apilarnil on insulin resistance and the possible underlying mechanism. In the study, 40 8 week-old male Wistar albino rats were used. The rats were divided into 5 groups as Control, Diabetes, Diabetes + Api1 (125 mg/kg/day … |
| Anahtar Kelimeler |
| Atıf Sayıları | |
| Web of Science | 2 |
| Scopus | 2 |
| Google Scholar | 2 |
| Dergi Adı | ACS Omega |
| Yayıncı | American Chemical Society |
| Açık Erişim | Evet |
| ISSN | 2470-1343 |
| E-ISSN | 2470-1343 |
| CiteScore | 7,1 |
| SJR | 0,773 |
| SNIP | 1,010 |